Protracted herpes zoster and severe postherpetic neuralgia after inadvertent infliximab administration

European Journal of Dermatology

Volumn 21, Issue 5, 2011, Pages 782-783

  Failla, Valérie ^a   Castronovo, Charlotte ^a   Meex, Cécile ^a   Nikkels, Arjen F ^a  

^a CHU SART TILMAN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; IMMUNOGLOBULIN E; INFLIXIMAB; PREGABALIN; VALACICLOVIR;

ADULT; ARTICLE; CASE REPORT; CROHN DISEASE; DISEASE SEVERITY; DRUG DOSE INCREASE; DRUG MEGADOSE; FEMALE; FOLLOW UP; HERPES ZOSTER; HOSPITAL ADMISSION; HUMAN; POSTHERPETIC NEURALGIA; SHOULDER PAIN; VARICELLA ZOSTER VIRUS;

ACYCLOVIR; ADMINISTRATION, ORAL; ADULT; ANTIBODIES, MONOCLONAL; ANTIVIRAL AGENTS; CROHN DISEASE; FEMALE; HERPES ZOSTER; HUMANS; NEURALGIA, POSTHERPETIC; TUMOR NECROSIS FACTOR-ALPHA; VALINE;

EID: 80054956034     PISSN: 11671122     EISSN: 19524013     Source Type: Journal    
DOI: 10.1684/ejd.2011.1424     Document Type: Article

References (6)

1. Strangfeld A, Listing J, Herzer P, et al. Risk of herpes zoster in patients with rheumatoid arthritis treated with anti-TNF-alpha agents. JAMA 2009; 301: 737-44.
2. Wallace MR, Woelfl I, Bowler WA, et al. Tumor necrosis factor, interleukin-2, and interferon-gamma in adult varicella. J Med Virol 1994; 43: 69-71.
3. Torigo S, Ihara T, Kamiya H. IL-12, IFN-gamma, and TNF-alpha released from mononuclear cells inhibit the spread of varicella-zoster virus at an early stage of varicella. Microbiol Immunol 2000; 44: 1027-31.
4. Black AP, Jones L, Malavige GN, Ogg GS. Immune evasion during varicella zoster virus infection of keratinocytes. Clin Exp Dermatol 2009; 34: e941-4.
5. Mizutani K, Ito M, Kamiya H, Sakurai M. Inhibition of varicellazoster virus glycoprotein expression by peripheral blood mononuclear cells. Microbiol Immunol 1995; 39: 217-20.
6. Nikkels AF, Sadzot-Delvaux C, Piérard GE. Absence of intercellular adhesion molecule 1 expression in varicella zoster virus-infected keratinocytes during herpes zoster: another immune evasion strategy? Am J Dermatopathol 2004; 26: 27-32.